Paul Wilmshurst and David Yurkerwich will be speaking on the topic of “Valuation Across Jurisdictions and Contexts.” Their session will be on valuation across jurisdictions and contexts will cover differences between litigation, licensing and tax/transfer pricing; potential impacts of the EU Unitary Patent and Unified Court; global transactions and licensing by patent aggregators; and the new global taxation environment for corporates.
For more information, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...